Guidance marks the regulatory body’s first on artificial intelligence applications in drug and biological product development.
FDA Issues New Recommendations for Use of Artificial Intelligence to Support Regulatory Actions
Guidance marks the regulatory body’s first on artificial intelligence applications in drug and biological product development.